ABOUT
Nowadays, many people face ongoing mental and physical health challenges that affect daily life. However, access to plant-based therapy options remains limited. PhytoXtract is committed to changing this by improving access to regulated, plant-based substances for medical use, while promoting quality, reliability, and environmental responsibility.
Plant-based narcotics
Regulated substances for medical use
PhytoXtract is a Swiss company based in Zurich and Geneva and among the first companies that was licensed by Swissmedic for medical cannabis.
Swiss quality
Reliable standards and cost efficiency
We manage the entire value chain – from cultivation and extraction to formulation and analysis – ensuring full compliance with GMP and GDP standards. Our focus on Swiss quality, reliable standards, and cost efficiency supports access to consistent, high-standard products for medical use.
OUR VALUES
SIMPLE
large product selection and possibility to order custom-made products as neededSIDE BY SIDE
regular visits from our specialists, training and access to research and market updatesSUSTAINABLE
commitment to environmental considerations from seed to salemedical cannabis : CBD and THC
The production of medical cannabis must follow strict GMP standards for both finished pharmaceutical products and active substances, in line with Swiss GMP and EU-GMP guidelines (Part I: pharmaceutical products, Part II: active ingredients). As a licensed manufacturer, PhytoXtract supports the production of fully regulated cannabis-based preparations, listed in the Swiss pharmacopoeia, and contributes to their safe and responsible availability.
It all begins with the plant. For outdoor cultivation, growers must follow GACP (Good Agricultural and Collection Practices). Indoor cultivation is subject to GMP (Good Manufacturing Practices), as it qualifies as pharmaceutical manufacturing. These regulatory frameworks form the foundation of our quality assurance system, ensuring consistent and traceable raw material quality. From carefully selected dried cannabis flowers, PhytoXtract manufactures pharmaceutical-grade cannabis raw materials as well as custom CBD/THC extracts and formulations tailored for pharmacies and pharmaceutical partners. We offer a variety of CBD:THC ratios in formats such as full-spectrum, broad-spectrum, and isolate-based oils, all produced under GMP conditions.
Beyond the pharmaceutical sector, we also serve broader industry needs. All product lines follow a fully traceable quality and compliance system, with in-house formulation and manufacturing of bulk extracts, white-label solutions, and raw materials for B2B partners.
CANMED - Information platform for prescribing physicians
Prescribing medical cannabis requires an individual approach, as tolerability and efficacy can vary from patient to patient. These differences are influenced by factors such as the endocannabinoid system, concomitant medication, and other individual characteristics.
CANMED provides physicians with evidence-based information, study summaries, and practical tools on the prescription of medical cannabis – designed to support clinical decision-making and everyday
Do you have any questions?
Please feel free to contact us at info@phytoxtract.ch for further information and support.
PhytoXtract is a Swissmedic-certified laboratory offering contract manufacturing services for magistral preparations and raw materials. Operating under strict GMP pharmaceutical standards, we ensure the highest level of quality, safety, and compliance.
Our expertise in extracting and processing medicinal plants enables us to deliver reliable, pharmaceutical-grade formulations and raw materials tailored to your needs. By partnering with PhytoXtract, pharmacies and pharmaceutical laboratories can confidently outsource production, streamline internal processes, and provide patients with customized, high-quality preparations, backed by the assurance of Swissmedic certification.
